Zoledronic acid Teva Generics Europeiska unionen - estniska - EMA (European Medicines Agency)

zoledronic acid teva generics

teva generics b.v - zoledroonhappe monohüdraat - osteoporosis; osteitis deformans - bisfosfonaadid - ravi osteoporosisin post-menopausis womenin täiskasvanud menat suurenenud risk luumurdude, sealhulgas hiljutine väike-trauma hip-murd. ravi osteoporoosi seotud pikaajalise süsteemse glükokortikoidi therapyin post-menopausis womenin täiskasvanud menat suurenenud risk luumurdude. ravi paget tõbi, luu täiskasvanutel.

Zoledronic acid Teva Pharma Europeiska unionen - estniska - EMA (European Medicines Agency)

zoledronic acid teva pharma

teva b.v. - zoledroonhape - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - narkootikumid luuhaiguste raviks - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. ravi paget tõbi, luu täiskasvanutel.

Pepaxti Europeiska unionen - estniska - EMA (European Medicines Agency)

pepaxti

oncopeptides ab - melphalan flufenamide hydrochloride - mitu müeloomit - antineoplastilised ained - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

GEMCITABINE HOSPIRA 38 MG/ML infusioonilahuse kontsentraat Estland - estniska - Ravimiamet

gemcitabine hospira 38 mg/ml infusioonilahuse kontsentraat

hospira uk limited - gemtsitabiin - infusioonilahuse kontsentraat - 38mg 1ml 52.6ml 1viaal; 38mg 1ml 5.3ml 1viaal; 38mg 1ml 26.3ml 1viaal

IRINOTECAN HOSPIRA 20MG/ML INFUSIOONILAHUSE KONTSENTRAAT infusioonilahuse kontsentraat Estland - estniska - Ravimiamet

irinotecan hospira 20mg/ml infusioonilahuse kontsentraat infusioonilahuse kontsentraat

hospira uk limited - irinotekaan - infusioonilahuse kontsentraat - 20mg 1ml 2ml 1tk

OXALIPLATIN HOSPIRA infusioonilahuse kontsentraat Estland - estniska - Ravimiamet

oxaliplatin hospira infusioonilahuse kontsentraat

hospira uk limited - oksaliplatiin - infusioonilahuse kontsentraat - 5mg 1ml 40ml 1tk; 5mg 1ml 20ml 1tk

DOCETAXEL HOSPIRA infusioonilahuse kontsentraat Estland - estniska - Ravimiamet

docetaxel hospira infusioonilahuse kontsentraat

hospira uk limited - dotsetakseel - infusioonilahuse kontsentraat - 10mg 1ml 8ml 1tk; 10mg 1ml 16ml 1tk; 10mg 1ml 2ml 1tk

Thymanax Europeiska unionen - estniska - EMA (European Medicines Agency)

thymanax

servier (ireland) industries ltd - agomelatine - depressiivne häire, suur - psychoanaleptics, - täiskasvanute suurte depressiivsete episoodide ravi.

Valdoxan Europeiska unionen - estniska - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatine - depressiivne häire, suur - psychoanaleptics, - täiskasvanute suurte depressiivsete episoodide ravi.

AGODEPRIN õhukese polümeerikattega tablett Estland - estniska - Ravimiamet

agodeprin õhukese polümeerikattega tablett

sandoz pharmaceuticals d.d. - agomelatiin - õhukese polümeerikattega tablett - 25mg 14tk; 25mg 7tk; 25mg 42tk; 25mg 28tk; 25mg 84tk; 25mg 98tk; 25mg 56tk; 25mg 100tk